{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:14:21Z","timestamp":1790172861190,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2006,4,25]],"date-time":"2006-04-25T00:00:00Z","timestamp":1145923200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2007,2,2]]},"DOI":"10.1007\/s10067-006-0302-6","type":"journal-article","created":{"date-parts":[[2006,4,24]],"date-time":"2006-04-24T13:16:26Z","timestamp":1145884586000},"page":"349-354","source":"Crossref","is-referenced-by-count":36,"title":["The natural course of progressive systemic sclerosis patients with interstitial lung involvement"],"prefix":"10.1007","volume":"26","author":[{"given":"Musellim","family":"Benan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikitimur","family":"Hande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ongen","family":"Gul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,4,25]]},"reference":[{"key":"302_CR1","first-page":"771","volume-title":"Oxford textbook of rheumatology","author":"CM Black","year":"1993","unstructured":"Black CM, Stephens SC (1993) Systemic sclerosis (scleroderma) and related disorders. In: Maddison PJ, Isenberg DA, Woo P, Glass DN (eds) Oxford textbook of rheumatology. Oxford University Press, Oxford, pp 771\u2013789"},{"key":"302_CR2","first-page":"1113","volume-title":"Arthritis and allied conditions","author":"TA Medsger","year":"1993","unstructured":"Medsger TA (1993) Systemic sclerosis (scleroderma), localized scleroderma, eosinophilic fasciitis and calcinosis. In: McCarty DJ, Koopman WJ (eds) Arthritis and allied conditions, 12th edn. Lea and Febiger, Philadelphia, pp 1113\u20131143","edition":"12"},{"key":"302_CR3","first-page":"1133","volume-title":"Textbook of rheumatology","author":"JR Seibold","year":"1997","unstructured":"Seibold JR (1997) Scleroderma. In: Kelley WN, Harris ED, Ruddy S, Sledge CB (eds) Textbook of rheumatology, 5th edn. Saunders, Philadelphia, pp 1133\u20131163","edition":"5"},{"key":"302_CR4","first-page":"1183","volume-title":"Cecil\u2019 s textbook of medicine","author":"EC Roy Le","year":"1996","unstructured":"Le Roy EC (1996) Systemic sclerosis (scleroderma). In: Bennet SC, Plumm F, Glass DN (eds) Cecil\u2019 s textbook of medicine. Saunders, Philadelphia, pp 1183\u20131188"},{"key":"302_CR5","first-page":"79.1","volume-title":"Rheumatology","author":"MF Wigley","year":"1998","unstructured":"Wigley MF (1998) Systemic sclerosis. In: Klippel JK, Dieppe PA (eds) Rheumatology. Mosby, St Louis, pp 79.1\u201379.14"},{"key":"302_CR6","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/ard.54.10.853","volume":"54","author":"DJ Veale","year":"1995","unstructured":"Veale DJ, Collidge TA, Belch JJ (1995) Increased prevalence of symptomatic macrovascular disease in systemic sclerosis. Ann Rheum Dis 54:853\u2013855","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"302_CR7","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/rheumatology\/27.4.286","volume":"27","author":"A Silman","year":"1988","unstructured":"Silman A, Jannini S, Symmons D et al (1988) An epidemiologic study of scleroderma in West Midlands. Br J Rheumatol 27(4):286\u2013290","journal-title":"Br J Rheumatol"},{"issue":"8","key":"302_CR8","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1136\/ard.53.8.502","volume":"53","author":"AJ Geirsson","year":"1994","unstructured":"Geirsson AJ, Steinsson K, Guthmundsson S et al (1994) Systemic sclerosis in Iceland. A nationwide epidemiologic study. Ann Rheum Dis 53(8):502\u2013505","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"302_CR9","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1046\/j.1445-5994.2001.00048.x","volume":"31","author":"PJ Roberts-Thomson","year":"2001","unstructured":"Roberts-Thomson PJ, Jones M, Hakendorf P et al (2001) Scleroderma in South Australia: epidemiological observations of possible pathogenic significance. Intern Med J 31(4):220\u2013229","journal-title":"Intern Med J"},{"issue":"3","key":"302_CR10","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/art.1780400309","volume":"40","author":"VD Steen","year":"1997","unstructured":"Steen VD, Oddis CV, Conte CG et al (1997) Incidence of systemic sclerosis in Allegheny County, Pennsylvania. A twenty-year study of hospital-diagnosed cases, 1963\u20131982. Arthritis Rheum 40(3):441\u2013445","journal-title":"Arthritis Rheum"},{"key":"302_CR11","first-page":"S150","volume":"39","author":"M Mayes","year":"1996","unstructured":"Mayes M, Laing T, Gillespie B et al (1996) Prevalence, incidence and survival rates of systemic sclerosis in the Detroit Metropolitan Area. Arthritis Rheum 39:S150, (Suppl)","journal-title":"Arthritis Rheum"},{"key":"302_CR12","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/ard.60.6.585","volume":"60","author":"AD Rossa","year":"2001","unstructured":"Rossa AD, Valentini G, Bombardieri S et al (2001) European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres. Ann Rheum Dis 60:585\u2013591","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"302_CR13","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/00002281-200111000-00008","volume":"13","author":"JG Coghlan","year":"2001","unstructured":"Coghlan JG, Mukerjee D (2001) The heart and pulmonary vasculature in scleroderma: clinical features and pathobiology. Curr Opin Rheumatol 13(6):495\u2013499","journal-title":"Curr Opin Rheumatol"},{"issue":"779","key":"302_CR14","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1259\/0007-1285-65-779-983","volume":"65","author":"SJ Garber","year":"1992","unstructured":"Garber SJ, Wells AU, duBois RM et al (1992) Enlarged mediastinal lymph nodes in the fibrosing alveolitis of systemic sclerosis. Br J Radiol 65(779):983\u2013986","journal-title":"Br J Radiol"},{"issue":"3","key":"302_CR15","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1148\/radiology.176.3.2389033","volume":"176","author":"H Schurawitzki","year":"1990","unstructured":"Schurawitzki H, Stiglbauer R, Granibger W et al (1990) Interstitial lung disease in progressive systemic sclerosis: high-resolution CT versus radiography. Radiology 176(3):755\u2013759","journal-title":"Radiology"},{"key":"302_CR16","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1378\/chest.114.3.801","volume":"114","author":"EL Griedinger","year":"1998","unstructured":"Griedinger EL, Flaherty KT, White B et al (1998) African American race and antibodies to topoisomerase I are associated with increased severity of scleroderma lung disease. Chest 114:801\u2013807","journal-title":"Chest"},{"issue":"9","key":"302_CR17","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/art.1780370903","volume":"7","author":"VD Steen","year":"1994","unstructured":"Steen VD, Conte C, Owens GR et al (1994) Severe restrictive lung disease in systemic sclerosis. Arthritis Rheum 37(9):1283\u20131289","journal-title":"Arthritis Rheum"},{"issue":"11","key":"302_CR18","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U","volume":"43","author":"VD Steen","year":"2000","unstructured":"Steen VD, Medsger JR TA (2000) Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 43 (11):2437\u20132444","journal-title":"Arthritis Rheum"},{"key":"302_CR19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1001\/archinte.1953.00240190097007","volume":"92","author":"WH Shuford","year":"1953","unstructured":"Shuford WH, Seaman WB, Goldman A (1953) Pulmonary manifestations of scleroderma. Arch Intern Med 92:85\u201397","journal-title":"Arch Intern Med"},{"key":"302_CR20","first-page":"754","volume":"42","author":"AL Weaver","year":"1987","unstructured":"Weaver AL, Divertie MB, Titus JL (1987) The lung in scleroderma. Mayo Clin Proc 42:754\u2013766","journal-title":"Mayo Clin Proc"},{"key":"302_CR21","doi-asserted-by":"crossref","first-page":"152","DOI":"10.7326\/0003-4819-32-1-152","volume":"32","author":"DM Spain","year":"1950","unstructured":"Spain DM, Thomas AG (1950) The pulmonary manifestations of scleroderma: an anatomic\u2013physiologic correlation. Ann Intern Med 32:152\u2013161","journal-title":"Ann Intern Med"},{"key":"302_CR22","first-page":"301","volume":"13","author":"GP Rodnan","year":"1963","unstructured":"Rodnan GP (1963) The natural history of progressive systemic sclerosis (diffuse scleroderma). Bull Rheum Dis 13:301\u2013304","journal-title":"Bull Rheum Dis"},{"key":"302_CR23","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0889-857X(03)00026-7","volume":"29","author":"TH Antony","year":"2003","unstructured":"Antony TH, Lin MD, Philip J et al (2003) Update on disease-modifying antirheumatic drugs in the treatment of systemic sclerosis. Rheum Dis Clin North Am 29:409\u2013426","journal-title":"Rheum Dis Clin North Am"},{"key":"302_CR24","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0889-857X(03)00025-5","volume":"29","author":"B White","year":"2003","unstructured":"White B (2003) Interstitial lung disease in scleroderma. Rheum Dis Clin North Am 29:371\u2013390","journal-title":"Rheum Dis Clin North Am"},{"issue":"3","key":"302_CR25","first-page":"581","volume":"23","author":"Subcomittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee","year":"1980","unstructured":"Subcomittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23(3):581\u2013586","journal-title":"Arthritis Rheum"},{"key":"302_CR26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ard.29.2.153","volume":"29","author":"R Bluestone","year":"1970","unstructured":"Bluestone R, Grahame R, Holloway V et al (1970) Treatment of systemic sclerosis with d-penisillamine. A new method of observing the effects of treatment. Ann Rheum Dis 29:153\u2013158","journal-title":"Ann Rheum Dis"},{"key":"302_CR27","doi-asserted-by":"crossref","first-page":"652","DOI":"10.7326\/0003-4819-97-5-652","volume":"97","author":"VD Steen","year":"1982","unstructured":"Steen VD, Medsger TA, Rodnan GP (1982) d-Penisillamine therapy in progressive systemic sclerosis (scleroderma): a retrospective analysis. Ann Intern Med 97:652\u2013659","journal-title":"Ann Intern Med"},{"key":"302_CR28","first-page":"1496","volume":"18","author":"SA Jimenez","year":"1991","unstructured":"Jimenez SA, Sigal SH (1991) A 15-year prospective study of treatment of rapidly progressive systemic sclerosis with d-penisillamine. J Rheumatol 18:1496\u20131503","journal-title":"J Rheumatol"},{"key":"302_CR29","first-page":"279","volume":"69","author":"B Kang","year":"1982","unstructured":"Kang B, Veres-Thorner C, Heredia R et al (1982) Successful treatment of far-advanced progressive systemic sclerosis by d-penicillamine. J Allergy Clin Immunol 69:279\u2013305","journal-title":"J Allergy Clin Immunol"},{"key":"302_CR30","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/art.1780280807","volume":"28","author":"VD Steen","year":"1985","unstructured":"Steen VD, Owens GR, Redmond C et al (1985) The effect of d-penisillamine on pulmonary findings in progressive systemic sclerosis. Arthritis Rheum 28:882\u2013888","journal-title":"Arthritis Rheum"},{"issue":"6","key":"302_CR31","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/art.1780300607","volume":"30","author":"LS DeClerck","year":"1987","unstructured":"DeClerck LS, Dequeker J, Francx L, Demedts M (1987) d-Penicillamine therapy and interstitial lung disease in scleroderma. Arthritis Rheum 30(6):643\u2013650","journal-title":"Arthritis Rheum"},{"key":"302_CR32","first-page":"36","volume":"5","author":"J Thomson","year":"1974","unstructured":"Thomson J, Milne JA (1974) Two years of penicillamine for progressive syclerosis: a case report. Postgrad Med J 5:36\u201338","journal-title":"Postgrad Med J"},{"key":"302_CR33","first-page":"313","volume":"10","author":"JD Smiley","year":"1967","unstructured":"Smiley JD, Johnson RL Jr, Ziff M (1967) Effect of d-penicillamine on pulmonary function in patients with progressive systemic sclerosis (abstract). Arthritis Rheum 10:313\u2013314","journal-title":"Arthritis Rheum"},{"key":"302_CR34","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/1529-0131(199906)42:6<1194::AID-ANR16>3.0.CO;2-7","volume":"42","author":"PJ Clements","year":"1999","unstructured":"Clements PJ, Furst DE, Wong WK et al (1999) High-dose versus low-dose d-penisillamine in early diffuse systemic sclerosis analysis of a two-year, double-blind, randomized, controlled clinical trial. Arthritis Rheum 42:1194\u20131203","journal-title":"Arthritis Rheum"},{"key":"302_CR35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.7326\/0003-4819-44-1-16","volume":"44","author":"GP Rodnan","year":"1956","unstructured":"Rodnan GP, Black RL, Bollet AJ, B\u00fdnim JJ (1956) Observations on the use of prednisone in patients with progressive systemic sclerosis (diffuse scleroderma). Ann Intern Med 44:16\u201329","journal-title":"Ann Intern Med"},{"key":"302_CR36","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0002-9343(89)80499-1","volume":"87","author":"FH Hoogen Van den","year":"1989","unstructured":"Van den Hoogen FH, Boerbooms AM, Van de Putte LB et al (1989) Methotrexate treatment in scleroderma. Am J Med 87:116\u2013117","journal-title":"Am J Med"},{"key":"302_CR37","first-page":"1763","volume":"18","author":"FH Hoogen Van den","year":"1991","unstructured":"Van den Hoogen FH, Boerbooms AM, Van de Putte LB et al (1991) Low dose methotrexate treatment in systemic sclerosis [letter]. J Rheumatol 18:1763\u20131764","journal-title":"J Rheumatol"},{"key":"302_CR38","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/rheumatology\/35.4.364","volume":"35","author":"FH Hoogen Van den","year":"1996","unstructured":"Van den Hoogen FH, Boerbooms AM, Swaak AJ et al (1996) Comparison of methotrexate with placebo in the treatment of systemic sclerosis: a 24\u00a0week randomized double-blind trial, followed by a 24\u00a0week observational trial. Br J Rheumatol 35:364\u2013372","journal-title":"Br J Rheumatol"},{"key":"302_CR39","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/1529-0131(200106)44:6<1351::AID-ART227>3.0.CO;2-I","volume":"44","author":"JE Pope","year":"2001","unstructured":"Pope JE, Bellamy N, Seibold JR et al (2001) A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma. Arthritis Rheum 44:1351\u20131358","journal-title":"Arthritis Rheum"},{"key":"302_CR40","first-page":"838","volume":"20","author":"RM Silver","year":"1993","unstructured":"Silver RM, Warrick JH, Kinsella MB et al (1993) Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease. J Rheumatol 20:838\u2013844","journal-title":"J Rheumatol"},{"key":"302_CR41","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/art.1780370518","volume":"37","author":"A Akesson","year":"1994","unstructured":"Akesson A, Scheja A, Lundin A et al (1994) Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamide. Arthritis Rheum 37:729\u2013735","journal-title":"Arthritis Rheum"},{"key":"302_CR42","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/art.1780370904","volume":"37","author":"VD Steen","year":"1994","unstructured":"Steen VD, Lanz KJ, Conte C et al (1994) Therapy for severe interstitial lung disease in systemic sclerosis. A retrospective study. Arthritis Rheum 37:1290\u20131296","journal-title":"Arthritis Rheum"},{"key":"302_CR43","first-page":"458","volume":"18","author":"E Davas","year":"1999","unstructured":"Davas E, Peppas C, Maragou M et al (1999) Intravenous cyclophosphamide pulse therapy for the treatment of lung disease associated with scleroderma. Clin Rheumatol 18:458\u2013461","journal-title":"Clin Rheumatol"},{"issue":"2","key":"302_CR44","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10067-005-1157-y","volume":"25","author":"O Nadashkevich","year":"2006","unstructured":"Nadashkevich O, Davis P, Fritzler M, Kovalenko W (2006) Randomized unblinded trial of cyclophosphamide versus azathioprine in the treatment of systemic sclerosis. Clin Rheumatol 25(2):205\u2013212","journal-title":"Clin Rheumatol"},{"key":"302_CR45","doi-asserted-by":"crossref","first-page":"947","DOI":"10.7326\/0003-4819-132-12-200006200-00004","volume":"132","author":"B White","year":"2000","unstructured":"White B, Moore WC, Wigley FM et al (2000) Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis. Ann Intern Med 132:947\u2013954","journal-title":"Ann Intern Med"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-006-0302-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-006-0302-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-006-0302-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:50:59Z","timestamp":1559119859000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-006-0302-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4,25]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,2,2]]}},"alternative-id":["302"],"URL":"https:\/\/doi.org\/10.1007\/s10067-006-0302-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4,25]]}}}